Affera Global Registry
ConditionAtrial Fibrillation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedtronic Cardiac Ablation Solutions
About this trial
The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.
Eligibility criteria
Qualifiers
Subject is ≥ 18 years of age or minimum age as required by local regulations
Planned procedure using the commercially available Affera Platform
Willing and able to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements
Disqualifiers
Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager
Subject with exclusion criteria required by local law
Trial design
Treatments tested in this trial
- Affera Platform
Treatment groups
540 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov